Time course of gene expression after plasmid DNA gene transfer to the liver

Journal of Gene Medicine

Volumn 3, Issue 3, 2001, Pages 280-291

  Herweijer, Hans ^a   Zhang, Guofeng ^a   Subbotin, Vladimir M ^b   Budker, Vladimir ^c   Williams, Phillip ^a   Wolff, Jon A ^c,d  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^d UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

CMV promoter; Intravascular; Liver; Non viral; Plasmid DNA; Sustained expression

Indexed keywords

CUCUMBER MOSAIC VIRUS;

DNA; LUCIFERASE;

ANIMAL; ARTICLE; CYTOLOGY; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; GENE VECTOR; GENETIC TRANSFECTION; GENETICS; INTRAVENOUS DRUG ADMINISTRATION; LIVER; METABOLISM; METHODOLOGY; MOUSE; MOUSE STRAIN; PLASMID; SOUTHERN BLOTTING; TIME;

ANIMALS; BLOTTING, SOUTHERN; DNA; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; INJECTIONS, INTRAVENOUS; LIVER; LUCIFERASES; MICE; MICE, INBRED STRAINS; PLASMIDS; TIME FACTORS; TRANSFECTION;

EID: 0035351210     PISSN: 1099498X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jgm.178     Document Type: Article

References (56)

1. Wolff JA, Yee JK, Skelly HF, et al. Expression of retrovirally transduced genes in primary cultures of adult rat hepatocytes. Proc Natl Acad Sci U S A 1987; 84: 3344-3348.
2. Anderson KD, Thompson JA, DiPietro JM, Montgomery KT, Reid LM, Anderson WF. Gene expression in implanted rat hepatocytes following retroviral-mediated gene transfer. Somat Cell Mol Genet 1989; 15: 215-227.
3. Hatzoglou M, Lamers W, Bosch F, Wynshaw-Boris A, Clapp DW, Hanson RW. Hepatic gene transfer in animals using retroviruses containing the promoter from the gene for phosphoenolpyruvate carboxykinase. J Biol Chem 1990; 265: 17285-17293.
4. Kaleko M, Garcia JV, Miller AD. Persistent gene expression after retroviral gene transfer into liver cells in vivo. Hum Gene Ther 1991; 2: 27-32.
5. Jaffe HA, Danel C, Longenecker G, et al. Adenovirus-mediated in vivo gene transfer and expression in normal rat liver. Nat Genet 1992; 1: 372-378.
6. Miyanohara A, Johnson PA, Elam RL, et al. Direct gene transfer to the liver with herpes simplex virus type 1 vectors: transient production of physiologically relevant levels of circulating factor IX. New Biol 1992; 4: 238-246.
7. Koeberl DD, Alexander IE, Halbert CL, Russell DW, Miller AD. Persistent expression of human clotting factor IX from mouse liver after intravenous injection of adeno-associated virus vectors. Proc Natl Acad Sci U S A 1997; 94: 1426-1431.
8. Snyder RO, Miao CH, Patijn GA, et al. Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors. Nat Genet 1997; 16: 270-276.
9. Fraefel C, Jacoby DR, Lage C, et al. Gene transfer into hepatocytes mediated by helper virus-free HSV/AAV hybrid vectors. Mol Med 1997; 3: 813-825.
10. Ferry N, Heard JM. Liver-directed gene transfer vectors. Hum Gene Ther 1998; 9: 1975-1981.
11. Bosch A, McCray Jr PB, Chang SM, et al. Proliferation induced by keratinocyte growth factor enhances in vivo retroviral-mediated gene transfer to mouse hepatocytes. J Clin Invest 1996; 98: 2683-2687.
12. Bosch A, McCray Jr PB, Walters KS, et al. Effects of keratinocyte and hepatocyte growth factor in vivo: implications for retrovirus-mediated gene transfer to liver. Hum Gene Ther 1998; 9: 1747-1754.
13. Kafri T, Blomer U, Peterson DA, Gage FH, Verma IM. Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors. Nat Genet 1997; 17: 314-317.
14. Jooss K, Ertl HC, Wilson JM. Cytotoxic T-lymphocyte target proteins and their major histocompatibility complex class I restriction in response to adenovirus vectors delivered to mouse liver. J Virol 1998; 72: 2945-2954.
15. Schiedner G, Morral N, Parks RJ, et al. Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity. Nat Genet 1998; 18: 180-183.
16. Snyder RO, Miao C, Meuse L, et al. Correction of hemophilia B in canine and murine models using recombinant adeno-associated viral vectors. Nat Med 1999; 5: 64-70.
17. Budker V, Zhang G, Knechtle S, Wolff JA. Naked DNA delivered intraportally expresses efficiently in hepatocytes. Gene Ther 1996; 3: 593-598.
18. Zhang G, Vargo D, Budker V, Armstrong N, Knechtle S, Wolff JA. Expression of naked plasmid DNA injected into the afferent and efferent vessels of rodent and dog livers. Hum Gene Ther 1997; 8: 1763-1772.
19. Zhang G, Budker V, Wolff JA. High levels of foreign gene expression in hepatocytes after tail vein injection of naked plasmid DNA. Hum Gene Ther 1999; 10: 1735-1737.
20. Liu F, Song YK, Liu D. Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Ther 1999; 6: 1258-1266.
21. Budker V, Budker T, Zhang G, Subbotin V, Loomis A, Wolff JA. Hypothesis: naked plasmid DNA is taken up by cells in vivo by a receptor-mediated process. J Gene Med 2000; 2: 76-88.
22. Palade GE, Simionescu M, Simionescu N. Structural aspects of the permeability of the microvascular endothelium. Acta Physiol Scand Suppl 1979; 463: 11-32.
23. Budker V, Zhang G, Danko I, Williams P, Wolff J. The efficient expression of intravascularly delivered DNA in rat muscle. Gene Ther 1998; 5: 272-276.
24. Danko I, Williams P, Herweijer H, et al. High expression of naked plasmid DNA in muscles of young rodents. Hum Mol Genet 1997; 6: 1435-1443.
25. Löser P, Sandig V, Kirillova I, Strauss M. Evaluation of HBV promoters for use in hepatic gene therapy. Biol Chem Hoppe Seyler 1996; 377: 187-193.
26. Kim DW, Harada T, Saito I, Miyamura T. An efficient expression vector for stable expression in human liver cells. Gene 1993; 134: 307-308.
27. Pinkert CA, Ornitz DM, Brinster RL, Palmiter RD. An albumin enhancer located 10 kb upstream functions along with its promoter to direct efficient, liver-specific expression in transgenic mice. Genes Dev 1987; 1: 268-276.
28. Manthorpe M, Cornefert-Jensen F, Hartikka J, et al. Gene therapy by intramuscular injection of plasmid DNA: studies on firefly luciferase gene expression in mice. Hum Gene Ther 1993; 4: 419-431.
29. Gao C, Jokerst R, Gondipalli P, et al. Lipopolysaccharide potentiates the effect of hepatocyte growth factor on hepatocyte replication in rats by augmenting AP-1 activity. Hepatology 1999; 30: 1405-1416.
30. Mombaerts P, Iacomini J, Johnson RS, Herrup K, Tonegawa S, Papaioannou VE. Rag-1-deficient mice have no mature B and T lymphocytes. Cell 1992; 68: 869-877.
31. Jacks T, Remington L, Williams BO, et al. Tumor spectrum analysis in p53-mutant mice. Curr Biol 1994; 4: 1-7.
32. Ikeda K, Clark JC, Shaw-White JR, Stahlman MT, Boutell CJ, Whitsett JA. Gene structure and expression of human thyroid transcription factor-1 in respiratory epithelial cells. J Biol Chem 1995; 270: 8108-8114.
33. Brauker J, Frost GH, Dwarki V, et al. Sustained expression of high levels of human factor IX from human cells implanted within an immunoisolation device into athymic rodents. Hum Gene Ther 1998; 9: 879-888.
34. Rashid A, Wu TC, Huang CC, et al. Mitochondrial proteins that regulate apoptosis and necrosis are induced in mouse fatty liver. Hepatology 1999; 29: 1131-1138.
35. Wilson GD. Assessment of human tumour proliferation using bromodeoxyuridine: current status. Acta Oncol 1991; 30: 903-910.
36. Graham JM. The isolation of nuclei and nuclear membranes from rat liver. Methods Mol Biol 1993; 19: 19-28.
37. Clark SJ, Harrison J, Paul CL, Frommer M. High sensitivity mapping of methylated cytosines. Nucleic Acids Res 1994; 22: 2990-2997.
38. Chowdhury NR, Hays RM, Bommineni VR, et al. Micro-tubular disruption prolongs the expression of human bilirubinuridinediphosphoglucuronate-glucuronosyltransferase-1 gene transferred into Gunn rat livers. J Biol Chem 1996; 271: 2341-2346.
39. Fausto N. Liver regeneration. J Hepatol 2000; 32: 19-31.
40. Furukawa S, Usuda K, Fujieda Y, et al. Apoptosis and cell proliferation in rat hepatocytes induced by barbiturates. J Vet Med Sci 2000; 62: 23-28.
41. Seki S, Abo T, Ohteki T, Sugiura K, Kumagai K. Unusual alpha beta-T cells expanded in autoimmune lpr mice are probably a counterpart of normal T cells in the liver. J Immunol 1991; 147: 1214-1221.
42. Abo T, Watanabe H, Iiai T, et al. Extrathymic pathways of T-cell differentiation in the liver and other organs. Int Rev Immunol 1994; 11: 61-102.
43. Vujanovic NL, Polimeno L, Azzarone A, et al. Changes of liver-resident NK cells during liver regeneration in rats. J Immunol 1995; 154: 6324-6338.
44. Shaw SG, Maung AA, Steptoe RJ, Thomson AW, Vujanovic NL. Expansion of functional NK cells in multiple tissue compartments of mice treated with flt3-ligand: implications for anti-cancer and anti-viral therapy. J Immunol 1998; 161: 2817-2824.
45. Wolff JA, Ludtke JJ, Acsadi G, Williams P, Jani A. Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle. Hum Mol Genet 1992; 1: 363-369.
46. Kovalovich K, DeAngelis RA, Li W, Furth EE, Ciliberto G, Taub R. Increased toxin-induced liver injury and fibrosis in interleukin-6-deficient mice. Hepatology 2000; 31: 149-159.
47. Löser P, Jennings GS, Strauss M, Sandig V. Reactivation of the previously silenced cytomegalovirus major immediate-early promoter in the mouse liver: involvement of NFκB. J Virol 1998; 72: 180-190.
48. Harms JS, Splitter GA. Interferon-gamma inhibits transgene expression driven by SV40 or CMV promoters but augments expression driven by the mammalian MHC I promoter. Hum Gene Ther 1995; 6: 1291-1297.
49. Krieg AM. Direct immunologic activities of CpG DNA and implications for gene therapy. J Gene Med 1999; 1: 56-63.
50. Walsh CP, Bestor TH. Cytosine methylation and mammalian development. Genes Dev 1999; 13: 26-34.
51. Hagstrom JN, Couto LB, Scallan C, et al. Improved muscle-derived expression of human coagulation factor IX from a skeletal actin/CMV hybrid enhancer/promoter. Blood 2000; 95: 2536-2542.
52. Miao CH, Ohashi K, Patijn GA, et al. Inclusion of the hepatic locus control region, an intron, and untranslated region increases and stabilizes hepatic factor IX gene expression in vivo but not in vitro. Mol Ther 2000; 1: 522-532.
53. Dai Y, Roman M, Naviaux RK, Verma IM. Gene therapy via primary myoblasts: long-term expression of factor IX protein following transplantation in vivo. Proc Natl Acad Sci U S A 1992; 89: 10892-10895.
54. Yant SR, Meuse L, Chiu W, Ivics Z, Izsvak Z, Kay MA. Somatic integration and long-term transgene expression in normal and haemophilic mice using a DNA transposon system. Nat Genet 2000; 25: 35-41.
55. Rettinger SD, Kennedy SC, Wu X, et al. Liver-directed gene therapy: quantitative evaluation of promoter elements by using in vivo retroviral transduction. Proc Natl Acad Sci U S A 1994; 91: 1460-1464.
56. Hafenrichter DG, Ponder KP, Rettinger SD, et al. Liver-directed gene therapy: evaluation of liver specific promoter elements. J Surg Res 1994; 56: 510-517.